InspireMD, Inc. (AMEX:NSPR) was founded in 2005 and is headquartered in Tel Aviv, Israel. It has 36 full-time employees. It is a medical device company focusing on the development and commercialization of the patented MicroNet stent platform technology for the treatment of coronary arteries and Vascular disease.
InspireMD, Inc. (NSPR):
InspireMD was established in 2005 to create a technology that can solve the embolization problem in high-risk vascular surgery. The company has grown to include a series of embolic protection systems, which can be produced and commercialized.
InspireMD provides CGuard carotid embolism prevention system for carotid artery applications; and MGuard main embolization protection system for patients with acute coronary syndromes, especially acute myocardial infarction and saphenous vein graft coronary intervention.
InspireMD is also developing NGuard, a neurovascular shunt that can divert blood flow from cerebral aneurysms to seal the aneurysm.
Today, InspireMD is a global company headquartered in Boston, Massachusetts. InspireMD aims to use its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing excellent solutions to key clinical problems in vascular surgery.
InspireMD distributes its products in Europe, Latin America, the Middle East and Asia.